Biomarkers for late-onset neonatal sepsis: cytokines and beyond.
Acute phase reactants, pro and antiinflammatory mediators including chemokines and cytokines, and cell-surface antigens are nonspecific biomarkers that have been extensively studied for the diagnosis and management of late-onset neonatal sepsis (LONS) and necrotizing enterocolitis. It is expected that the next generation of biomarkers and tests will be more specific, will pinpoint the precise disease entity, and will provide crucial information on the exact pathogen or category of microorganism and its antibiotic profile within hours of clinical presentation. Research on molecular pathogen detection and proteomic profiling has shown promising results. Academic-industry partnerships are vital for successful development of new diagnostic biomarkers for LONS, which are sensitive, inexpensive, fully automated, and easy to measure, allowing a quick turnaround time for clinical decision making.
Ng
Pak C
PC
Department of Pediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong. pakcheungng@cuhk.edu.hk
Lam
Hugh S
HS
D000954:Antigens, Surface / Q000097:blood*; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000378:metabolism*; D016207:Cytokines / Q000097:blood*; D003937:Diagnosis, Differential; D006801:Humans; D007231:Infant, Newborn; D018805:Sepsis / Q000097:blood* / Q000175:diagnosis
D000954:Antigens, Surface; D015415:Biomarkers; D016207:Cytokines; D002097:C-Reactive Protein
Pediatrics. 2004 Jul;114(1):1-8
15231900
Pediatr Res. 2004 Nov;56(5):804-9
15319462
Pediatrics. 2002 Jul;110(1 Pt 1):36-41
12093944
Crit Care Med. 2009 Aug;37(8):2441-7
19531943
Clin Perinatol. 2010 Jun;37(2):355-74
20569812
Pediatr Res. 2007 Jan;61(1):93-8
17211148
Neonatology. 2007;91(2):107-13
17344660
Lancet. 1998 Oct 17;352(9136):1271-7
9788457
Pediatrics. 2008 Jan;121(1):129-34
18166566
Pediatr Res. 2002 Mar;51(3):296-303
11861933
Pediatr Res. 2005 Feb;57(2):270-5
15585684
J Infect Dis. 2003 Sep 15;188(6):919-26
12964125
J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8
7989463
J Pediatr. 2000 Sep;137(3):345-50
10969258
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F551-4
15499153
Arch Dis Child Fetal Neonatal Ed. 2003 May;88(3):F209-13
12719394
Acta Paediatr. 2007 Aug;96(8):1122-5
17578489
Intensive Care Med. 2004 Jul;30(7):1454-60
15127192
J Clin Invest. 2010 Aug;120(8):2989-3000
20592468
Pediatrics. 2000 Jul;106(1):E4
10878173
J Pediatr. 2003 Jul;143(1):3-4
12915813
Arch Dis Child Fetal Neonatal Ed. 1997 Nov;77(3):F221-7
9462194
Pediatr Infect Dis J. 1995 May;14(5):362-6
7638010
Biol Neonate. 2005;87(2):105-10
15539766
Pediatrics. 2002 Aug;110(2 Pt 1):285-91
12165580
Clin Perinatol. 2010 Jun;37(2):411-9
20569815
Clin Lab Haematol. 1999 Oct;21(5):365-8
10646081
Pediatr Res. 2003 Sep;54(3):344-52
12815110
J Perinat Med. 2004;32(2):176-80
15085896
Pediatr Res. 2004 Nov;56(5):796-803
15371562
J Immunol. 2005 Jan 15;174(2):1104-10
15634936
Pediatrics. 2001 Jul;108(1):E12
11433091
Lancet. 1998 Mar 28;351(9107):950-3
9734942
Clin Exp Immunol. 2004 Aug;137(2):402-7
15270859
J Paediatr Child Health. 2000 Oct;36(5):509-10
11036812
J Pediatr. 2003 Jul;143(1):11-5
12915817
Arch Dis Child Fetal Neonatal Ed. 2004 May;89(3):F229-35
15102726
Nat Rev Immunol. 2004 Feb;4(2):133-42
15040586
J Clin Microbiol. 2008 Aug;46(8):2613-9
18550744
J Pediatr. 1998 Mar;132(3 Pt 1):445-51
9544899
J Pediatr. 1988 May;112(5):761-7
3361389
Clin Chem. 2006 Jun;52(6):1181-9
16613997
J Clin Microbiol. 2005 May;43(5):2291-302
15872258
J Clin Microbiol. 2006 Jan;44(1):119-23
16390958
Pediatrics. 2005 Nov;116(5):1064-9
16263990
Ann Clin Biochem. 2002 Mar;39(Pt 2):130-5
11928760
Antimicrob Agents Chemother. 2003 Oct;47(10):3290-5
14506043
Clin Infect Dis. 1998 Mar;26(3):664-72
9524841
Pathology. 2008 Feb;40(2):141-8
18203036